This topic contains a solution. Click here to go to the answer

Author Question: Which of the following designs is the best in terms of eliminating potential confounds? a. ... (Read 67 times)

mspears3

  • Hero Member
  • *****
  • Posts: 586
Which of the following designs is the best in terms of eliminating potential confounds?
 
  a. nonequivalent comparison group
  b. posttest-only design with nonequivalent groups
  c. pretest-posttest control-group design
  d. interrupted time series design

Question 2

Dr. Staines has repeatedly read that multiple personality disorder does not occur in elderly males, yet she is currently working in private practice with an 80-year-old man who fits diagnostic criteria for the disorder.
 
  She publishes her notes on her work with this person to show that the prevailing wisdom is not completely correct. She has done a(n) study.
 
 a. intrinsic case
  b. longitudinal
  c. geriatric
   d. instrumental case



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ecabral0

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

C

Answer to Question 2

D




mspears3

  • Member
  • Posts: 586
Reply 2 on: Jul 13, 2018
Excellent


billybob123

  • Member
  • Posts: 336
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Walt Disney helped combat malaria by making an animated film in 1943 called The Winged Scourge. This short film starred the seven dwarfs and taught children that mosquitos transmit malaria, which is a very bad disease. It advocated the killing of mosquitos to stop the disease.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library